FOXY
ActiveSummary
FOXY has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €135,799 and a net result of €3,022. Equity is growing by ~18.1% per year across the filed fiscal years. Its solvency ranks better than 80% of 526 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2023
Profitability71▼-7
Solvency100=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10,000 at 30 days acceptable
Liquidity short (current ratio 0.39 against 1.35 in 2023; short-term debt: 8.5% and cash: 1.5% of total assets), and 11.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
88.4%
Return on assets
2%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
31 d late
2023
30 d late
2022
on the day
2021
12 d early
2020
1 d early
2019
31 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 3 days after the deadline; the sector median for financial year 2023 is 12 days before the deadline, and 35% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (5 of the last 5 filed years within 31 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Turnover
€0
2021 · €0
Total assets
€153,611▼ 9.5%
2023 · €169,643
Net result
€3,022▼ 77.0%
2023 · €13,142
Working capital
-€7,870
2023 · €8,344
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232025
Turnover€0€0
Operating result€80,282▲ 439%€30,108▼ 62.5%€38,600▲ 28.2%€18,738▼ 51.5%€6,749-
Net result€56,918within the sector's middle half▲ 457%€21,691within the sector's middle half▼ 61.9%€30,475within the sector's middle half▲ 40.5%€13,142within the sector's middle half▼ 56.9%€3,022within the sector's middle half-
Equity€76,533within the sector's middle half▲ 290%€94,024within the sector's middle half▲ 22.9%€120,299within the sector's middle half▲ 27.9%€133,440within the sector's middle half▲ 10.9%€135,799within the sector's middle half-
Total assets€134,608within the sector's middle half▲ 63.0%€155,370within the sector's middle half▲ 15.4%€169,603within the sector's middle half▲ 9.2%€169,643within the sector's middle half=€153,611within the sector's middle half-
Debt€58,074▼ 7.8%€61,346▲ 5.6%€49,305▼ 19.6%€36,203▼ 26.6%€17,813-
Working capital-€2,496below the sector's middle half▲ 92.2%-€18,873below the sector's middle half▼ 656%-€4,566below the sector's middle half▲ 75.8%€8,344below the sector's middle half-€7,870below the sector's middle half-
Solvency56.9%within the sector's middle half▲ 33.1pp60.5%within the sector's middle half▲ 3.7pp70.9%within the sector's middle half▲ 10.4pp78.7%within the sector's middle half▲ 7.7pp88.4%above the sector's middle half-
Current ratio0.94below the sector's middle half▲ 0.490.62below the sector's middle half▼ 0.330.88below the sector's middle half▲ 0.271.35within the sector's middle half▲ 0.460.39below the sector's middle half-
Return on assets (ROA)42.3%above the sector's middle half▲ 29.9pp14.0%within the sector's middle half▼ 28.3pp18.0%within the sector's middle half▲ 4.0pp7.7%within the sector's middle half▼ 10.2pp2.0%within the sector's middle half-
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result is €6,749 in 2025, compared with €18,738 in 2023. Comparable figures for the intervening years are unavailable.
Balance-sheet composition
2025 in colour, 2023 as the grey bar beneath
Assets €153,611
Fixed assets
€148,477 ▲ 8.2%
Current assets
€5,135 ▼ 84.1%
Equity and liabilities €153,611
Equity
€135,799 ▲ 1.8%
Debt
€17,813 ▼ 50.8%
Debt's share of the balance-sheet total falls from 21.3% to 11.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€11,945▼
2023 · €23,935
Cash flow
€8,218▼
2023 · €18,338
Debt to equity
0.13▼
2023 · 0.27
ROE
2.2%▼
2023 · 9.8%
Interest coverage
15.58▼
2023 · 86.55
Debt ≤ 1 year
€13,005▼
2023 · €24,030
Debt > 1 year
€4,807▼
2023 · €12,172
Income taxes
€2,962▼
2023 · €5,342
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | - | €0 | €0 | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | €0 | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,820 | €1,647 | €4,506 | €5,196 | €5,196 | - |
| Other operating charges640/8 | - | €467 | €506 | €605 | €888 | - |
| Gross operating margin9900 | €82,509 | €32,221 | €43,612 | €24,539 | €12,833 | - |
| Operating profit (loss)9901 | €80,282 | €30,108 | €38,600 | €18,738 | €6,749 | - |
| Financial income75/76B | - | - | €56 | €22 | €1 | - |
| Recurring financial income75 | €0 | - | €56 | €22 | €1 | - |
| Financial charges65/66B | - | €917 | €1,003 | €277 | €767 | - |
| Recurring financial charges65 | €303 | €917 | €1,003 | €277 | €767 | - |
| Profit (loss) for the period before taxes9903 | €79,979 | €29,191 | €37,653 | €18,483 | €5,983 | - |
| Income taxes67/77 | €23,061 | €7,500 | €7,178 | €5,342 | €2,962 | - |
| Profit (loss) for the period9904 | €56,918 | €21,691 | €30,475 | €13,142 | €3,022 | - |
| Profit (loss) for the period to be appropriated9905 | €56,918 | €21,691 | €30,475 | €13,142 | €3,022 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €134,608 | €155,370 | €169,603 | €169,643 | €153,611 | - |
| Fixed assets21/28 | €93,358 | €124,916 | €134,702 | €137,269 | €148,477 | - |
| Tangible fixed assets22/27 | €16,730 | €28,968 | €38,754 | €26,322 | €15,929 | - |
| Land and buildings22 | - | €28,968 | €27,321 | €17,746 | €13,071 | - |
| Furniture and vehicles24 | - | €0 | €11,434 | €8,575 | €2,858 | - |
| Financial fixed assets28 | €76,628 | €95,948 | €95,948 | €110,948 | €132,548 | - |
| Current assets29/58 | €41,250 | €30,454 | €34,901 | €32,374 | €5,135 | - |
| Amounts receivable within one year40/41 | €14,399 | €19,615 | €17,896 | €15,263 | €2,754 | - |
| Trade receivables40 | - | €19,615 | €17,896 | €15,250 | €2,730 | - |
| Other amounts receivable41 | - | €0 | €0 | €14 | €24 | - |
| Cash at bank and in hand54/58 | €26,851 | €10,839 | €17,005 | €3,753 | €2,380 | - |
| Deferred charges and accrued income490/1 | - | - | - | €13,357 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €134,608 | €155,370 | €169,603 | €169,643 | €153,611 | - |
| Equity10/15 | €76,533 | €94,024 | €120,299 | €133,440 | €135,799 | - |
| Contributions10/11 | €12,400 | €12,400 | €12,400 | €12,400 | €12,400 | - |
| Capital10 | - | €12,400 | €12,400 | - | - | - |
| Issued capital100 | - | €18,600 | €18,600 | - | - | - |
| Uncalled capital101 | - | €6,200 | €6,200 | - | - | - |
| Reserves13 | €1,860 | €1,860 | €1,860 | €1,860 | €11,160 | - |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | - | - | - |
| Legal reserve130 | - | €1,860 | €1,860 | - | - | - |
| Distributable reserves133 | - | - | - | €1,860 | €11,160 | - |
| Profit (loss) carried forward14 | €62,273 | €79,764 | €106,039 | €119,180 | €112,239 | - |
| Amounts payable17/49 | €58,074 | €61,346 | €49,305 | €36,203 | €17,813 | - |
| Amounts payable after more than one year17 | €14,329 | €12,019 | €9,837 | €12,172 | €4,807 | - |
| Financial debts170/4 | - | €12,019 | €9,837 | €12,172 | - | - |
| Other amounts payable178/9 | - | - | - | - | €4,807 | - |
| Amounts payable within one year42/48 | €43,746 | €49,327 | €39,467 | €24,030 | €13,005 | - |
| Current portion of amounts payable after more than one year42 | - | €1,960 | €7,777 | €5,306 | €216 | - |
| Trade debts44 | €13,579 | €7,975 | €8,012 | €1,641 | €2,018 | - |
| Suppliers440/4 | - | €7,975 | €8,012 | €1,641 | €2,018 | - |
| Taxes, remuneration and social security45 | - | €35,192 | €19,479 | €17,083 | €7,270 | - |
| Taxes450/3 | - | €35,192 | €19,479 | €17,083 | €7,270 | - |
| Other amounts payable47/48 | - | €4,200 | €4,200 | €0 | €3,500 | - |
| Accrued charges and deferred income492/3 | - | - | - | - | €0 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €56,918 | €21,691 | €30,475 | €13,142 | €3,022 | - |
| + Depreciation and write-downs630 | €1,820 | €1,647 | €4,506 | €5,196 | €5,196 | - |
| Operating cash flow (approximation) | €58,738 | €23,338 | €34,981 | €18,338 | €8,218 | - |
| Investment in fixed assets (approximation) | - | -€33,205 | -€14,292 | -€7,764 | - | - |
| Change in cash | - | -€16,012 | €6,166 | -€13,252 | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Weakest financial yearnet €3,022 ▼77%
Net result drops to €3,022, the lowest in the series.
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100,000Eq €120,299 ▲27.9%
4 profitable years in a row build equity to €120,299.
19-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Highest result since 2019net €56,918 ▲457%
Operating result €80,282, net result €56,918, both a record.
30-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vielsalm · 1 establishment unit since 2018
Ground area
1.8 ha
Building footprint
404 m²
Parcel 82011A3181/00K000, Wallonia. Linked by address, not a title deed.
8
companies at this address
See who is registered here
1 establishment unit
Mont-le-Soie 1, 6698 Vielsalm
since 20182.283.945.568
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 82011A3181/00K000 | Wallonia | 1.8 ha | 1 · 404 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
OPIS BELGIUM
BE 0525.925.288
Brussel · Eq €134,831
Dr. D. FRANCOIS PHOTOMED
BE 0892.140.474
Sint-Jans-Molenbeek · Eq €133,704
TympRes
BE 0445.711.337
Lovendegem · Eq €133,673
MDC Kestens
BE 0761.576.395
Lille · Eq €138,343
HUMAN WAVES
BE 0846.710.228
Charleroi · Eq €132,989
Of 762 companies in sector 72101 we hold annual accounts for 484. 303 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded26-10-2018
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
E-invoicing
Reachable via Peppol
Peppol ID
0208:0712621881
Also
9925:BE0712621881
Registered
18-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.